Gå til hovedindhold

WGSCAN_ENG Information concerning comprehensive analysis for hereditary cancer

A short description of the genetic analysis and how the result can affect you and your family if a pathogenic variant (mutation) is detected.

Genetic Counselling Regarding Comprehensive Genetic Testing for Suspected Hereditary Cancer (Adults)

Comprehensive genetic testing for suspected hereditary cancer

You have been referred for genetic counselling because hereditary cancer is suspected in you or your family. As part of this process, you have been offered comprehensive genetic testing called whole-genome sequencing (WGS).

The purpose of the test is to determine whether you carry a genetic alteration that may increase your risk of developing cancer.

This patient information explains:

  • What types of results the test may provide.
  • What the results may mean for you and your family.

If you have any questions, please feel free to contact the genetic counsellor or doctor responsible for your care at the Department of Genetics.

The genetic test

Humans have approximately 20,000 genes. Comprehensive genetic testing involves sequencing your entire genome. However, we only analyse the genes known to be associated with an increased risk of developing cancer. This typically involves 200–400 genes.

The test is usually performed using a blood sample, but in certain cases it may also be performed using a skin biopsy or tissue from a deceased relative.

The analysis may identify whether you carry a disease-causing genetic variant (pathogenic variant) that increases your risk of developing cancer. It may also identify genetic variants associated with an increased risk of other types of cancer than those occurring in your family.

Consent to testing through the National Genome Center (NGC)

Before the genetic test can be performed, you must sign a consent form for the National Genome Center (NGC). This is referred to as NGC consent. Your genetic data will be stored in the NGC's national database.

As part of the consent process, you will be asked to indicate whether you wish to be informed if the test identifies additional genetic findings unrelated to the suspected hereditary cancer. These are referred to as secondary findings.

Secondary findings are disease-causing genetic variants that are not responsible for the condition or suspected hereditary cancer that originally led to the genetic test.

For example, a genetic variant that increases the risk of hereditary cardiovascular disease may be identified.

The likelihood of identifying such genetic variants is very low, as the analysis is focused on genes associated with an increased risk of developing cancer.

You will receive further information about NGC consent during your genetic counselling appointment.

If a disease-causing genetic variant is identified

If the test identifies one or more disease-causing genetic variants, your doctor or genetic counsellor will inform you of the results as agreed. You will usually also be offered an appointment with a doctor.

During the consultation, you will receive further information about:

  • What the finding means for you.
  • How the genetic variant is inherited.
  • The risk of cancer associated with the genetic variant.
  • What surveillance programme, if any, may be offered to you.
  • Whether genetic testing of your family members is relevant and, if so, how they can be offered genetic testing.

If no disease-causing genetic variant is identified

If no disease-causing genetic variant is identified, this does not rule out the possibility that you carry a genetic alteration that increases your risk of developing cancer.

This is partly because our knowledge of genes is still limited and current genetic testing methods cannot detect all types of genetic alterations.

Your genetic counsellor or doctor will assess whether a surveillance programme should be recommended for you or your family members based on the occurrence of cancer in your family, even if the test has not identified a disease-causing genetic variant.

Variants of uncertain significance

In some cases, genetic testing may identify genetic variants whose significance for health is not yet known. These are called variants of uncertain significance (VUS).

Variants of uncertain significance are a common finding in genetic testing. As a general rule, such a finding does not lead to changes in surveillance or treatment, nor does it provide an indication for genetic testing of family members.

In some cases, additional laboratory investigations or other analyses may help clarify the significance of a variant. If this is relevant and possible, your genetic counsellor or doctor will inform you accordingly.

 

Redaktør
Klik for at scrolle op eller ned p� siden G� til toppen af siden